对降低突变亨廷顿蛋白对亨廷顿病治疗治疗的等位基选择性方法的洞察
Jia-Yuan Yao1, Ting Liu2, Xin-Ru Hu1
1The First Clinical College, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning Province 110122, PR China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|October 15, 2024
概括
亨廷顿病 (HD) 的治疗方法缺乏. 本综述探讨了针对突变亨廷丁 (mHTT) DNA,RNA或蛋白质的等位基因选择性疗法,为HD治疗研究提供了有前途的途径.
科学领域:
- 神经退行性疾病 神经退行性疾病
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 亨廷顿病 (HD) 是一种单一性神经退行性疾病,由亨廷丁基因 (HTT) 中的CAG重复扩张引起.
- 扩大的CAG重复导致突变猎蛋白 (mHTT) 的有毒功能增加.
- 目前,没有有效的治疗方法可以阻止HD的进展.
研究的目的:
- 审查针对亨廷顿病选择性向突变型亨廷丁 (mHTT) 的治疗策略.
- 评估基因组选择性mHTT降低方法的临床前和临床结果.
- 识别HD治疗研究的挑战和潜在的新想法.
主要方法:
- 关于亨廷顿病的等位基选择性疗法科学文献的综述.
- 针对突变狩猎丁基因 (HTT) DNA,RNA和蛋白质的方法分析.
- 对新兴的HD治疗方法的临床前和临床数据的检查.
主要成果:
- 选择性降低mHTT表达的等位基因为HD提供了一个有前途的治疗策略.
- 针对突变的HTTDNA,RNA或mHTT蛋白本身是关键的方法.
- 几项临床前和临床研究显示出潜力,但面临挑战.
结论:
- 开发可以选择性地减少mHTT的疗法,同时保留野生类型的猎蛋白 (wtHTT) 对于HD治疗至关重要.
- 同位素选择性策略为亨廷顿病治疗提供了一条有前途的前进道路.
- 需要进一步的研究来克服挑战,并推进这些新型的HD治疗方法.
更多相关视频
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018
7.9K
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
2.5K
相关概念视频
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...